Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028

Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028

The global cystatin C assay market is projected to reach USD 540 million by 2028 from USD 377 million in 2023, at a CAGR of 7.5% during the forecast period. The growth of this market is majorly driven by Increasing number of diabetes population as increasing prevalence of diabetes and hypertension, both risk factors for kidney disease, has heightened the need for early and accurate kidney function assessments.. However, Challenges associated with cost and affordability may threat the growth of this market.

“US’ Analyzer in the product segment to witness the highest growth during the forecast period in the north American market.”

Based north american region analyzer’ portion, the cystatin C assay market is segmented into US and Cananda. US is projected to grow at the highest CAGR during the forecast period. The United States is a significant market for medical devices and diagnostic equipment, including cystatin C analyzers, the demand for such analyzers is driven by healthcare needs and laboratory practices. Factors such as the prevalence of kidney diseases, clinical guidelines, laboratory infrastructure, and technological advancements influence the adoption of cystatin C analyzers in US.

“Europe is estimated to register the third highest CAGR during the forecast period.”

In this report, the cystatin C assay market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of significant aging population, with a higher proportion of individuals aged 65 and above. The aging demographic is more prone to chronic conditions, such as diabetes nephopathy, and chronic nephrological conditions , which often require diagnostic tesing moreover, ongoing advancements in assay technologies, including the availability of automated analyzers and point-of-care testing options, have improved the accessibility and efficiency of cystatin C testing in Europe.

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (48%), Tier 2 (34%), and Tier 3 (18%)

By Designation: C-level (33%), Director-level (40%), and Others (27%)

By Region: North America (36%), Europe (28%), AsiaPacific (20%), Rest of the World (16%)

List of Companies Profiled in the Report

Gentian Diagnostics ASA (Norway)

Getein Biotech, Inc. (China)

Abbott (US)

Roche Diagnostics Limited.(Switzerland)

Siemens Healthcare GmbH (Germany)

Thermo Fisher Scientific Inc. (US)

Agilent Technologies, Inc. (US)

Abcam plc. (UK)

Sino Biological, Inc. (China)

Bio-Techne (US)

Eurolyser Diagnostica GmbH (Austria)

Diazyme Laboratories, Inc (US)

KAMIYA BIOMEDICAL COMPANY (US)

Randox Laboratories Ltd. (UK)

DiaSys Diagnostic Systems GmbH (Germany)

Cepham Life Sciences (US)

ETHOS BIOSCIENCES (US)

ImmunoDiagnostics Limited.(Cananda)

SEKISUI Diagnostics (US)

Aalto Scientific, Ltd (US)

RayBiotech Life, Inc. (US)

Arbor Assays (US)

CUSABIO TECHNOLOGY LLC (US)

Proteintech Group, Inc. (US)

Zhejiang Kangte Biotechnology Co., Ltd.(China)

Research Coverage:

This report studies the cystatin C assay market based on product and region. The report also analyzes factors (such as drivers, opportunities, and challenges, restraints) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cystatin C assay market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on bio decontamination products offered by the top 25 players in the cystatin C assay market. The report analyzes the cystatin C assay market by product, method, application, sample type, end user and region.

Market Drivers: Comprehensive information about the factors and conditions that stimulate and influence the growth and performance of a specific market.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cystatin C assay market.

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cystatin C assay market.